Accordingly, Noxa levels are unaffected by oncogenic KRAS expression and other pathways, such as the ones controlled by PI3K/AKT, protect cancer cells from the potentially pro-apoptotic stimulus of mutated KRAS. The gene discussed is PMAIP1; the disease is cancer.